{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T04:00:46Z","timestamp":1791086446256,"version":"4.1.0"},"reference-count":43,"publisher":"American Society of Hematology","issue":"7","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The persistence of human T-cell leukemia\/lymphoma virus-I (HTLV-I)\u2013infected cells is dependent upon clonal expansion and up-regulation of telomerase (hTERT). We have previously found that in interleukin (IL)\u20132\u2013independent transformed HTLV-I cells, Tax strongly activates the hTERT promoter through nuclear factor-\u03baB (NF-\u03baB)\u2013mediated Sp1 and c-Myc activation. In IL-2\u2013dependent cells and adult T-cell leukemia\/lymphoma (ATLL) patient samples, however, Tax expression is very low to undetectable, yet these cells retain strong telomerase activity. This suggests the existence of compensatory mechanisms in IL-2\u2013dependent cells and ATLL patients. In this study, we demonstrate that telomerase activity is significantly decreased upon IL-2 withdrawal in immortalized HTLV-I cell lines. Inhibition of PI3K or AKT signaling pathways reduced telomerase activity in HTLV-I cells. We found that IL-2\/IL-2R signaling was associated with a PI3K-dependent\/AKT-independent transcriptional up-regulation of the endogenous hTERT promoter. We found that activation of the PI3K pathway mediated cytoplasmic retention of the Wilms tumor (WTI) protein, which strongly suppressed the hTERT promoter. The importance of this regulatory pathway for telomerase expression is underscored by findings that the PI3K pathway is commonly found activated in cancer cells.<\/jats:p>","DOI":"10.1182\/blood-2008-01-134692","type":"journal-article","created":{"date-parts":[[2008,5,29]],"date-time":"2008-05-29T21:25:28Z","timestamp":1212096328000},"page":"2946-2955","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":42,"title":["Central role of PI3K in transcriptional activation of hTERT in HTLV-I\u2013infected cells"],"prefix":"10.1182","volume":"112","author":[{"given":"Marcia","family":"Bellon","sequence":"first","affiliation":[{"name":"Department of Microbiology, Immunology, and Molecular Genetics, University of Kansas Medical Center, Kansas City"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Nicot","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Immunology, and Molecular Genetics, University of Kansas Medical Center, Kansas City"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111713464784100_B1","doi-asserted-by":"crossref","first-page":"i109","DOI":"10.1136\/ard.59.suppl_1.i109","article-title":"Advances in interleukin 2 receptor targeted treatment.","volume":"59","author":"Morris","year":"2000","journal-title":"Ann Rheum Dis"},{"key":"2019111713464784100_B2","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.cytogfr.2006.07.003","article-title":"Both integrated and differential regulation of components of the IL-2\/IL-2 receptor system.","volume":"17","author":"Kim","year":"2006","journal-title":"Cytokine Growth Factor Rev"},{"key":"2019111713464784100_B3","doi-asserted-by":"crossref","first-page":"7415","DOI":"10.1073\/pnas.77.12.7415","article-title":"Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma.","volume":"77","author":"Poiesz","year":"1980","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111713464784100_B4","doi-asserted-by":"crossref","first-page":"13897","DOI":"10.1073\/pnas.94.25.13897","article-title":"Proliferation of adult T cell leukemia\/lymphoma cells is associated with the constitutive activation of JAK\/STAT proteins.","volume":"94","author":"Takemoto","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111713464784100_B5","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1126\/science.7604283","article-title":"Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-I.","volume":"269","author":"Migone","year":"1995","journal-title":"Science"},{"key":"2019111713464784100_B6","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1172\/JCI118193","article-title":"Constitutive activation of different Jak tyrosine kinases in human T cell leukemia virus type 1 (HTLV-1) tax protein or virus-transformed cells.","volume":"96","author":"Xu","year":"1995","journal-title":"J Clin Invest"},{"key":"2019111713464784100_B7","doi-asserted-by":"crossref","first-page":"5097","DOI":"10.4049\/jimmunol.165.9.5097","article-title":"Functional uncoupling of the Janus kinase 3-Stat5 pathway in malignant growth of human T cell leukemia virus type 1-transformed human T cells.","volume":"165","author":"Kirken","year":"2000","journal-title":"J Immunol"},{"key":"2019111713464784100_B8","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood.V96.1.275","article-title":"Bcl-X(L) is up-regulated by HTLV-I and HTLV-II in vitro and in ex vivo ATLL samples.","volume":"96","author":"Nicot","year":"2000","journal-title":"Blood"},{"key":"2019111713464784100_B9","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1182\/blood-2006-01-0067","article-title":"Persistent inhibition of telomerase reprograms adult T-cell leukemia to p53-dependent senescence.","volume":"108","author":"Datta","year":"2006","journal-title":"Blood"},{"key":"2019111713464784100_B10","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0092-8674(01)00492-5","article-title":"Switching and signaling at the telomere.","volume":"106","author":"Blackburn","year":"2001","journal-title":"Cell"},{"key":"2019111713464784100_B11","first-page":"645","article-title":"Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues.","volume":"56","author":"Avilion","year":"1996","journal-title":"Cancer Res"},{"key":"2019111713464784100_B12","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/sj.onc.1201882","article-title":"Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomerase.","volume":"16","author":"Counter","year":"1998","journal-title":"Oncogene"},{"key":"2019111713464784100_B13","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1182\/blood-2003-12-4251","article-title":"Transcriptional activation of hTERT through the NF-kappaB pathway in HTLV-I-transformed cells.","volume":"104","author":"Sinha-Datta","year":"2004","journal-title":"Blood"},{"key":"2019111713464784100_B14","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1002\/ijc.22026","article-title":"Increased expression of telomere length regulating factors TRF1, TRF2 and TIN2 in patients with adult T-cell leukemia.","volume":"119","author":"Bellon","year":"2006","journal-title":"Int J Cancer"},{"key":"2019111713464784100_B15","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1038\/sj.onc.1203536","article-title":"HTLV-I Tax transrepresses the human c-Myb promoter independently of its interaction with CBP or p300.","volume":"19","author":"Nicot","year":"2000","journal-title":"Oncogene"},{"key":"2019111713464784100_B16","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ygyno.2005.08.053","article-title":"Rapamycin inhibits hTERT telomerase mRNA expression, independent of cell cycle arrest.","volume":"100","author":"Bae-Jump","year":"2006","journal-title":"Gynecol Oncol"},{"key":"2019111713464784100_B17","doi-asserted-by":"crossref","first-page":"6091","DOI":"10.1073\/pnas.93.12.6091","article-title":"Cell cycle-dependent modulation of telomerase activity in tumor cells.","volume":"93","author":"Zhu","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111713464784100_B18","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1091\/mbc.e05-09-0903","article-title":"Cell cycle-regulated trafficking of human telomerase to telomeres.","volume":"17","author":"Tomlinson","year":"2006","journal-title":"Mol Biol Cell"},{"key":"2019111713464784100_B19","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1006\/bbrc.1994.2480","article-title":"Role of phosphatidylinositol-3-kinase in insulin receptor signaling: studies with inhibitor, LY294002.","volume":"204","author":"Sanchez-Margalet","year":"1994","journal-title":"Biochem Biophys Res Commun"},{"key":"2019111713464784100_B20","doi-asserted-by":"crossref","first-page":"15213","DOI":"10.1073\/pnas.0507184102","article-title":"Alteration of phosphatidylinositol 3-kinase cascade in the multilobulated nuclear formation of adult T cell leukemia\/lymphoma (ATLL).","volume":"102","author":"Fukuda","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111713464784100_B21","doi-asserted-by":"crossref","first-page":"6719","DOI":"10.1038\/sj.onc.1208825","article-title":"Activated AKT regulates NF-kappaB activation, p53 inhibition and cell survival in HTLV-1-transformed cells.","volume":"24","author":"Jeong","year":"2005","journal-title":"Oncogene"},{"key":"2019111713464784100_B22","doi-asserted-by":"crossref","first-page":"13085","DOI":"10.1074\/jbc.274.19.13085","article-title":"Akt protein kinase enhances human telomerase activity through phosphorylation of telomerase reverse transcriptase subunit.","volume":"274","author":"Kang","year":"1999","journal-title":"J Biol Chem"},{"key":"2019111713464784100_B23","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.leukres.2006.08.001","article-title":"Longitudinal inhibition of PI3K\/Akt\/mTOR signaling by LY294002 and rapamycin induces growth arrest of adult T-cell leukemia cells.","volume":"31","author":"Ikezoe","year":"2007","journal-title":"Leuk Res"},{"key":"2019111713464784100_B24","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1742-4690-3-22","article-title":"Inhibition of constitutively active Jak-Stat pathway suppresses cell growth of human T-cell leukemia virus type 1-infected T-cell lines and primary adult T-cell leukemia cells.","volume":"3","author":"Tomita","year":"2006","journal-title":"Retrovirology"},{"key":"2019111713464784100_B25","doi-asserted-by":"crossref","first-page":"5097","DOI":"10.4049\/jimmunol.165.9.5097","article-title":"Functional uncoupling of the Janus kinase 3-Stat5 pathway in malignant growth of human T cell leukemia virus type 1-transformed human T cells.","volume":"165","author":"Kirken","year":"2000","journal-title":"J Immunol"},{"key":"2019111713464784100_B26","doi-asserted-by":"crossref","first-page":"10687","DOI":"10.1073\/pnas.94.20.10687","article-title":"Lack of cell cycle regulation of telomerase activity in human cells.","volume":"94","author":"Holt","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111713464784100_B27","first-page":"18","article-title":"Nuclear factor-kappaB p65 mediates tumor necrosis factor alpha-induced nuclear translocation of telomerase reverse transcriptase protein.","volume":"63","author":"Akiyama","year":"2003","journal-title":"Cancer Res"},{"key":"2019111713464784100_B28","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/nar\/28.3.669","article-title":"Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT).","volume":"28","author":"Kyo","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"2019111713464784100_B29","first-page":"2116","article-title":"Expression of the hTERT gene is regulated at the level of transcriptional initiation and repressed by Mad1.","volume":"60","author":"Gunes","year":"2000","journal-title":"Cancer Res"},{"key":"2019111713464784100_B30","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/sj.bjc.6603008","article-title":"hTERT phosphorylation by PKC is essential for telomerase holoprotein integrity and enzyme activity in head neck cancer cells.","volume":"94","author":"Chang","year":"2006","journal-title":"Br J Cancer"},{"key":"2019111713464784100_B31","doi-asserted-by":"crossref","first-page":"37473","DOI":"10.1074\/jbc.274.52.37473","article-title":"The Wilms' tumor 1 tumor suppressor gene represses transcription of the human telomerase reverse transcriptase gene.","volume":"274","author":"Oh","year":"1999","journal-title":"J Biol Chem"},{"key":"2019111713464784100_B32","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1038\/sj.onc.1201391","article-title":"Inhibition of the DNA-binding and transcriptional repression activity of the Wilms' tumor gene product, WT1, by cAMP-dependent protein kinase-mediated phosphorylation of Ser-365 and Ser-393 in the zinc finger domain.","volume":"15","author":"Sakamoto","year":"1997","journal-title":"Oncogene"},{"key":"2019111713464784100_B33","doi-asserted-by":"crossref","first-page":"5606","DOI":"10.1002\/j.1460-2075.1996.tb00945.x","article-title":"Regulation of WT1 by phosphorylation: inhibition of DNA binding, alteration of transcriptional activity and cellular translocation.","volume":"15","author":"Ye","year":"1996","journal-title":"EMBO J"},{"key":"2019111713464784100_B34","first-page":"21","article-title":"Telomerase: a crucial player in HTLV-I-induced human T-cell leukemia.","volume":"4","author":"Bellon","year":"2007","journal-title":"Cancer Genomics Proteomics"},{"key":"2019111713464784100_B35","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/sj.leu.2404624","article-title":"A tumor suppressor and oncogene: the WT1 story.","volume":"21","author":"Yang","year":"2007","journal-title":"Leukemia"},{"key":"2019111713464784100_B36","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1093\/emboj\/20.8.1897","article-title":"The Wilms tumor suppressor WT1 directs stage-specific quiescence and differentiation of human hematopoietic progenitor cells.","volume":"20","author":"Ellisen","year":"2001","journal-title":"EMBO J"},{"key":"2019111713464784100_B37","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1038\/sj.leu.2402303","article-title":"Forced expression of the Wilms tumor 1 (WT1) gene inhibits proliferation of human hematopoietic CD34(+) progenitor cells.","volume":"15","author":"Svedberg","year":"2001","journal-title":"Leukemia"},{"key":"2019111713464784100_B38","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1182\/blood.V87.7.2878.bloodjournal8772878","article-title":"Growth inhibition of human leukemic cells by WT1 (Wilms tumor gene) antisense oligodeoxynucleotides: implications for the involvement of WT1 in leukemogenesis.","volume":"87","author":"Yamagami","year":"1996","journal-title":"Blood"},{"key":"2019111713464784100_B39","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1038\/sj.leu.2404878","article-title":"Effective treatment of leukemic cell lines with wt1 siRNA.","volume":"21","author":"Glienke","year":"2007","journal-title":"Leukemia"},{"key":"2019111713464784100_B40","doi-asserted-by":"crossref","first-page":"6207","DOI":"10.1073\/pnas.81.19.6207","article-title":"Human T-cell leukemia virus (HTLV-I) transcripts in fresh and cultured cells of patients with adult T-cell leukemia.","volume":"81","author":"Franchini","year":"1984","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111713464784100_B41","doi-asserted-by":"crossref","first-page":"5620","DOI":"10.1073\/pnas.86.14.5620","article-title":"Detection of mRNA for the tax1\/rex1 gene of human T-cell leukemia virus type I in fresh peripheral blood mononuclear cells of adult T-cell leukemia patients and viral carriers by using the polymerase chain reaction.","volume":"86","author":"Kinoshita","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111713464784100_B42","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1172\/JCI111992","article-title":"Interleukin-2 receptor (Tac antigen) expressed on adult T cell leukemia cells.","volume":"76","author":"Uchiyama","year":"1985","journal-title":"J Clin Invest"},{"key":"2019111713464784100_B43","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/jnci\/djm269","article-title":"Regulation of telomerase and telomeres: human tumor viruses take control.","volume":"100","author":"Bellon","year":"2008","journal-title":"J Natl Cancer Inst"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/112\/7\/2946\/1303014\/zh801908002946.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/112\/7\/2946\/1303014\/zh801908002946.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,17]],"date-time":"2019-11-17T13:47:03Z","timestamp":1573998423000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/112\/7\/2946\/24770\/Central-role-of-PI3K-in-transcriptional-activation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10,1]]},"references-count":43,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2008,10,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2008-01-134692","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10,1]]}}}